Hart Health Strategies Inc. is a bi-partisan consulting and lobbying firm specializing in legislative and regulatory health care issues. The Hart Health Strategies Inc. team has extensive experience working on federal health care legislation and the rulemaking process.
The Latest
Republicans Secure Majority in House for 119th Congress
Republicans Secure Majority in House for 119th Congress-Republicans have officially won enough seats to retain majority control of the House of Representatives for the 119th Congress. While five races remain uncalled, the balance of power currently stands at 218 seats for Republicans and 212 seats for Democrats. On the Senate side, Pennsylvania party officials are …
“HHS' expertise in legislative, regulatory, and insurer policy has made it an invaluable partner in my organization's advocacy initiatives.”
- Dr. Howard Rogers, President of the American College of Mohs Surgery (2022-2023)
“Whether working on the state or federal level, in legislative or regulatory activities, Hart Health keeps us up-to-date on the issues and sets us up with meetings with all the right people.”
- Madelaine A. Feldman, MD, FACR, VP, Advocacy & Govt. Affairs, Coalition of State Rheumatology Organizations (CSRO)
Our Team
Our Team
The professionals at Hart Health Strategies have bipartisan, bicameral, legislative experience and also have multi-talented backgrounds in health-related fields.
With combined decades of service working on Capitol Hill, the professionals at Hart Health Strategies Inc. have a strong understanding of all aspects of health policy and advocacy. Collectively, during their time on Capitol Hill, our team members were responsible for negotiating health-related legislation before all of the major healthcare committees and congressional leadership.
Regulatory & Quality:
The Hart Health Strategies Inc. team has federal health agency experience, which is critical to understanding the regulatory process and the implementation of federal law and congressional directives. Our staff members have worked at the National Institutes of Health, the Centers for Disease Control and Prevention, the Agency for Healthcare Research and Quality, and the Office of Management and Budget.
State Advocacy:
The Hart Health Strategies Inc. state advocacy team has over a decade of experience working with state legislatures and regulators across the United States. Our firm specializes in grassroots advocacy efforts to enhance opportunities for provider and patient engagement with lawmakers. Our unique network of legislative relationships and industry contacts has helped secure policy successes in all 50 U.S. states. The team also develops and leads strategic alliances and coalitions and provides Advocacy 101 training, committee testimony, policy negotiations, communication campaigns, contract counsel management, Capitol Day organization and execution, public speaking, and other related government affairs activities within the states.
Strategic Planning:
Hart Health Strategies Inc. assists clients with strategic planning activities, including developing tools that describe how legislative and regulatory advocacy supports the client's broader mission, vision, and objectives. We assist clients in anticipating outcomes, translating the current political and regulatory climate into direction and action. We believe such strategic planning is critical, particularly since meaningfully connecting advocacy efforts to a client's strategic plan can change the perception of government relations engagement from a "cost center" to an "opportunity center."
Coalition Building:
Hart Health Strategies Inc. has in-depth experience working on a variety of health policy issues and has done so on behalf of numerous organizations over the years. Through our relationships and expertise, we are uniquely positioned to recognize when an organization's interests coincide on priority issues and how to bring together diverse groups to speak with a common purpose. This well-practiced approach allows our clients to achieve a greater impact on both their legislative and regulatory agendas.